ANXA2 and ovarian cancer: ANXA2 and human epididymis protein 4 (HE4) are interacting proteins, and the binding between them can activate various signaling pathways, such as the MAPK and FOCAL pathways, thereby promoting the invasion, metastasis, and epithelial-mesenchymal transition (EMT) of ovarian cancer cells [27].